Target intelligence / Profile preview

Adherence to psycho-behavioral programs

Molecular classification
Other
01

Overview

Adherence to psycho-behavioral programs is defined as the extent to which a patient's behavior—such as attending therapy sessions, practicing cognitive-behavioral techniques, or implementing lifestyle modifications—coincides with the agreed-upon recommendations from a healthcare provider (WHO, 2003). It is not a molecular target, such as a receptor or enzyme, but rather a multifaceted clinical phenomenon influenced by psychological, social, and economic factors (NIH, 2021). Adherence is a critical determinant of therapeutic success, particularly in the management of chronic conditions like depression, substance use disorders, and obesity, where behavioral change is the primary driver of health outcomes (StatPearls, 2023). While no drugs interact with adherence as a molecular substrate, various pharmacological agents (e.g., those used in medication-assisted treatment for addiction) are prescribed to stabilize patients and improve their capacity to adhere to comprehensive behavioral programs (PubMed, 2022). Poor adherence remains a major challenge in medicine, often leading to suboptimal therapeutic efficacy and increased mortality rates (NIH, 2021).

Other names
Treatment adherencePatient complianceTherapeutic adherenceBehavioral adherenceClinical adherencePersistence with therapy
02

Mechanism of action

Not applicable; this is a behavioral outcome and clinical metric rather than a molecular site of drug action.

03

Biological functions

Behavioral regulationCognitive processesSelf-regulation
04

Disease associations

Chronic disease managementMental health disordersSubstance use disordersMetabolic syndromeCardiovascular disease
05

Safety considerations

Treatment failureDisease relapse or progressionIncreased risk of hospitalizationDevelopment of drug resistance (e.g., in infectious diseases)Higher healthcare costs
06

Biomarkers

Electronic monitoring systems (e.g., MEMS caps)Self-report scales (e.g., Morisky Medication Adherence Scale)Pill countsBiochemical verification (drug/metabolite levels in blood or urine)Attendance records for clinical sessions

Beyond the preview

Go deeper on Adherence to psycho-behavioral programs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adherence to psycho-behavioral programs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call